Antipsychotic withdrawal – an unrecognized and misdiagnosed problem
It’s not withdrawal, it’s a relapse of your illness.
This is what many people trying to stop their antipsychotic drugs are told when seeking support...
Scientists find new way to predict deadly brain cancer
In a study from the University of Waterloo and elsewhere, scientists have created a computational model to predict the growth of deadly brain tumours...
This study shows a key contributor to high blood pressure
High blood pressure increases the risk of heart disease and stroke, two leading causes of death for Americans.
High blood pressure is also very common....
The ‘guardian of the genome’ can help prevent heart disease
In a study from the Centro Nacional de Investigaciones Cardiovasculares and elsewhere, scientists found that acquired mutations in the gene encoding the protein p53...
Scientists find strong links between depression, anxiety and ADHD
In a study from the University of Bath, scientists found people with high levels of attention-deficit hyperactivity disorder (ADHD) symptoms are more likely to...
This simple method can detect and cure most common cause of high blood pressure
In a study from the Queen Mary University of London and elsewhere, scientists found a new type of CT scan to light up tiny...
Long COVID may last indefinitely for some people, study finds
In a study from Scripps Research Translational Institute and elsewhere, scientists found that long COVID may last indefinitely for some people.
They suggest that long COVID...
High-fat diet causes inflammation in brain, linked to dementia
In a study from Michigan Medicine, scientists have discovered that a high-fat diet promotes an early inflammatory response in the brains of mice through an immune...
What you need to know about XBB.1.5, the latest omicron variant
Four weeks ago, the XBB.1.5 variant caused less than 10% of COVID-19 cases in the U.S. Now it causes more than 25% of them.
This new test can improve ovarian cancer treatment
Scientists developed a genetic test that can identify ovarian cancer patients who benefit from PARP inhibitors, a treatment option.